S-1/CDDP and Lentinan for Advanced Stomach cancer
- Conditions
- advanced gastric cancer
- Registration Number
- JPRN-UMIN000007726
- Lead Sponsor
- Chiba University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1)Serious drug hypersesitivity 2)Active infection 3)Clitical condition of heart disease 4)Serious coexisting illness diabetes mellitus,uncontrolled or controlled with insulin,liver cirrhosis,renal disfunction,severe pulmonary dysfunction,bowel dysfunction,history of myocardial infarction 5)Massive hydrothorax or ascites 6)Multiple bone metastases 7)Brain metastasis 8)Active bleeding of digestive tract 9)Diarrhea 10)Severe mental disorders 11)Have other cancers than gastric cancer 12)Pregnant or nursing 13)Pregnant or nursing 14)Not suitable for participating in the study for any other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method feasibility,PFS,OS,TTF,RR,Clinical benefit rate(CBR),G/L,QO